Patent Applications
Home Preeclampsia Technology Intellectual property Management News Contact

APT has several patents pending that cover a broad range of

apheresis technology for the treatment of preeclampsia.

APT has received the assignment for the exclusive rights to key patents and associated intellectual property from the inventors of this technology: Dr. Henry Smith and Dr. James Smith. The inventors are the first individuals to propose the removal of sFlt-1 using an apheresis method for the treatment of preeclampsia. The following patent applications have been published and are currently under review by the US Patent and Trademark Office. US Patent Application 12/415,585 US Patent Application 13/374,814 APT’s founders continue to innovate new technologies and have additional patents pending (unpublished). APT believes that its innovative device designs and associated trade secrets will provide APT with an enduring competitive edge.

Targeted Therapy for Preeclampsia

Intellectual Property
Copyright © 2013     Advanced Prenatal Therapeutics, Inc  Terms of Use Privacy Policy
Images courtesy of taoty (top) and papaija2008 (bottom) via FreeDigitalPhotos; and Eric Baets (center) via Wikimedia Commons.
Intellectual property